Baseline characteristics.

<p>Data are presented as mean ± standard deviation or as median with range.</p><p>‡) Cardiovascular disease was defined as ≥ 1 known conditions (placebo/ARB): Ischemic heart disease (9/8); arrhythmia (6/5); valvular disease (6/3); heart failure (0/1); LV: Left ventricular;</p><p>#)Tx: Kidney transplantation;</p><p>§) Charlson comorbidity index score range 0–37; 0 = low, 3+ = high; DDD = Defined daily doses; EPO: erythropoetin;</p><p>a) n = 39 (Placebo group);</p><p>b) n = 36 (Placebo group);</p><p>GFR: glomerular filtration rate based on the mean of urinary creatinine and urea clearance as previously described [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0126882#pone.0126882.ref025" target="_blank">25</a>]; bpm: beats per minute; HDF: hemodiafiltration; HD: hemodialysis;</p><p>c) Three patients in the placebo group and two patients in the ARB group had dialysis vintage > one year and four patients (two in each group) had urine output < 300 mL/day due to delay after inclusion/screening.</p><p>Baseline characteristics.